Starton Therapeutics (Starton Therapeutics) Long-Term Capital Lease Obligation : $1.42 Mil (As of Jun. 2023)

View and export this data going back to 2050. Start your Free Trial

What is Starton Therapeutics Long-Term Capital Lease Obligation?

Starton Therapeutics's Long-Term Capital Lease Obligation for the quarter that ended in Jun. 2023 was $1.42 Mil.

Starton Therapeutics's quarterly Long-Term Capital Lease Obligation declined from Dec. 2022 ($1.48 Mil) to Mar. 2023 ($1.45 Mil) and declined from Mar. 2023 ($1.45 Mil) to Jun. 2023 ($1.42 Mil).

Starton Therapeutics's annual Long-Term Capital Lease Obligation declined from Mar. 2021 ($1.57 Mil) to Mar. 2022 ($1.56 Mil) and declined from Mar. 2022 ($1.56 Mil) to Mar. 2023 ($1.45 Mil).

Starton Therapeutics Long-Term Capital Lease Obligation Historical Data

The historical data trend for Starton Therapeutics's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starton Therapeutics Long-Term Capital Lease Obligation Chart

Starton Therapeutics Annual Data

Trend

Mar21

Mar22

Mar23

Long-Term Capital Lease Obligation

1.57

1.56

1.45

Starton Therapeutics Quarterly Data
	Mar21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial			1.56	-	1.48	1.45	1.42

Starton Therapeutics (NAS:STA) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Starton Therapeutics Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Starton Therapeutics's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Starton Therapeutics (Starton Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starton Therapeutics Inc (NAS:STA) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

215 College Road, Suite No.300, Paramus, NJ, USA, 07652

Website

https://www.startontx.com

Starton Therapeutics Inc is a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, and longer. Starton's proprietary continuous delivery technology can increase the efficacy of approved drugs, make them more tolerable, and expand their potential use.

Starton Therapeutics (Starton Therapeutics) Headlines

No Headlines